Overweight and/or Obesity

Metabolic Diseases
1
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Sciwind Biosciences
Sciwind BiosciencesChina - Hangzhou
1 program
1
ecnoglutide tabletsPhase 1/2Peptide1 trial
Active Trials
NCT07243171RecruitingEst. Nov 2026
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Endoscopic Radial Compression GastroplastyN/A1 trial
Active Trials
NCT07237750RecruitingEst. May 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Sciwind Biosciencesecnoglutide tablets
City TherapeuticsEndoscopic Radial Compression Gastroplasty

Clinical Trials (2)

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Start: Nov 2025Est. completion: Nov 2026
Phase 1/2Recruiting
NCT07237750City TherapeuticsEndoscopic Radial Compression Gastroplasty

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Start: Jan 2026Est. completion: May 2027
N/ARecruiting

Related Jobs in Metabolic Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials
2 companies competing in this space